Table 2.
The association between DENV serotype combinations and disease severity (DF/DHF) in co-infections with respect to their anti-DENV IgM/IgG status
| Final diagnosis | DENV serotype combination | Anti-DENV IgM/IgG status (n; %) | Total (n; %) | |
|---|---|---|---|---|
| Primary | Secondary | |||
| DF (n = 23) | DENV-1 + DENV-2 | 5; 15.2 | 7; 21.2 | 12; 36.4 |
| DENV-1 + DENV-3 | 0 | 3; 9.1 | 3; 9.1 | |
| DENV-2 + DENV-3 | 5; 15.2 | 0 | 5; 15.2 | |
| DENV-1 + DENV-4 | 1; 3 | 0 | 1; 3 | |
| DENV-3 + DENV-4 | 1; 3 | 0 | 1; 3 | |
| DENV-1 + DENV-3 + DENV-4 | 0 | 1; 3 | 1; 3 | |
| DHF (n = 10) | DENV-1 + DENV-2 | 2; 6.1 | 5; 15 | 7; 21.2 |
| DENV-1 + DENV-3 | 0 | 1; 3 | 1; 3 | |
| DENV-2 + DENV-3 | 2; 6.1 | 0 | 2; 6.1 | |
| Total | 16; 48.5 | 17; 51.5 | 33; 100 | |